Corum Pharma SRL
Corum Pharma reported total assets of €2.33m at the end of the 2026 financial year (annual accounts filed with the NBB on 26 Oct 2026).
The score of Corum Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2026
Change 2023 → 2026: Equity +14 % Total assets +1 %
Accounts of the company itself (not consolidated).
The full file covers 5 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Corum Pharma's annual accounts
Filed annual accounts
- Year ended 31 Mar 2026filed on 26 Oct 2026
- Year ended 31 Mar 2025filed on 31 Oct 2025
- Year ended 31 Mar 2024filed on 28 Oct 2024
- Year ended 31 Mar 2023filed on 30 Oct 2023
- Year ended 31 Mar 2022filed on 03 Nov 2022
Corum Pharma's financial analysis
- Solvency74.7%sector median: 55.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Corum Pharma
Corum Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0763.652.492
- VAT number
- BE0763652492
- Peppol
- Registered · 0208:0763652492 · as of 11 Nov 2026
- Legal form
- SRL
- Incorporated
- 15 Feb 2021
- Registered office
- 8710 Wielsbeke
- Latest accounts
- 2026 · filed on 26 Oct 2026
- Activity
- Activities of holding companies (NACE 64210)
Corum Pharma (SRL) has been based in Wielsbeke since 2021, active in: activities of holding companies. For 2026, it reports a net profit of 67,004 € and equity of €1.74m; its revenue is not published. Its solvency stands at 74.7%, above the median of its sector (55.6%).
Companies similar to Corum Pharma
Companies in the same business, of comparable size and area, outside its group.
- Compuvision Partners Activities of holding companies Ypres · balance sheet €2.33m
- Brista Activities of holding companies Nijlen · balance sheet €2.33m
- HMS Projects Management Activities of holding companies Knokke-Heist · balance sheet €2.33m
- THE Brick Holding Activities of holding companies Antwerp · balance sheet €2.32m
- Kantoor Saelen Activities of holding companies Izegem · balance sheet €2.32m
- HG Service Brokers Activities of holding companies Schoten · balance sheet €2.33m
- Legaci Holding Activities of holding companies Heusden-Zolder · balance sheet €2.32m
- Berfil Activities of holding companies Alken · balance sheet €2.32m
Frequently asked questions about Corum Pharma
What is the revenue of Corum Pharma?
Corum Pharma files its accounts in a format where revenue is optional: it is not published for 2026.
What is the VAT number of Corum Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0763652492 for Corum Pharma, if the company is VAT-registered. Its company number (CBE) is 0763.652.492.
Where is the registered office of Corum Pharma?
According to the CBE register, the registered office of Corum Pharma is in 8710 Wielsbeke.
What is the equity of Corum Pharma?
At the close of the 2026 financial year, the equity of Corum Pharma amounts to 1,737,734 €, a solvency of 74.7% of total assets.
Who manages Corum Pharma?
The register lists 2 active mandates at Corum Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Corum Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →